Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 317

1.

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.

Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME, Lumry WR.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):348-53. doi: 10.2500/aap.2012.33.3585.

PMID:
22856635
2.

Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.

Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):49-53. doi: 10.1016/j.anai.2011.10.017. Epub 2011 Nov 21.

PMID:
22192966
3.

Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.

Lyseng-Williamson KA.

BioDrugs. 2011 Oct 1;25(5):317-27. doi: 10.2165/11208390-000000000-00000. Review.

PMID:
21942916
4.

Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women.

Baker JW, Craig TJ, Riedl MA, Banerji A, Fitts D, Kalfus IN, Uknis ME.

Allergy Asthma Proc. 2013 Mar-Apr;34(2):162-9. doi: 10.2500/aap.2013.34.3645.

PMID:
23484892
5.

Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.

Lumry W, Manning ME, Hurewitz DS, Davis-Lorton M, Fitts D, Kalfus IN, Uknis ME.

J Pediatr. 2013 May;162(5):1017-22.e1-2. doi: 10.1016/j.jpeds.2012.11.030. Epub 2013 Jan 11.

PMID:
23312695
6.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):354-61. doi: 10.2500/aap.2012.33.3589.

PMID:
22856636
7.

Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.

Riedl MA, Lumry WR, Li HH, Craig TJ, Fitts D, Kalfus I, Uknis ME.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):517-21. doi: 10.2500/ajra.2013.27.3973.

PMID:
24274230
8.

C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.

Craig TJ, Bewtra AK, Bahna SL, Hurewitz D, Schneider LC, Levy RJ, Moy JN, Offenberger J, Jacobson KW, Yang WH, Eidelman F, Janss G, Packer FR, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy. 2011 Dec;66(12):1604-11. doi: 10.1111/j.1398-9995.2011.02702.x. Epub 2011 Sep 2.

9.

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.

Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.

Clin Exp Allergy. 2012 Jun;42(6):929-35. doi: 10.1111/j.1365-2222.2012.03984.x.

PMID:
22909164
10.

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.

Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ.

Allergy Asthma Proc. 2012 May-Jun;33(3):235-40. doi: 10.2500/aap.2012.33.3573. Review.

PMID:
22584192
11.

Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.

Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF.

Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16.

PMID:
22197071
12.

Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.

Jurado-Palomo J, Muñoz-Caro JM, López-Serrano MC, Prior N, Cabañas R, Pedrosa M, Burgueño M, Caballero T.

J Investig Allergol Clin Immunol. 2013;23(1):1-6.

13.

Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.

Bernstein JA, Manning ME, Li H, White MV, Baker J, Lumry WR, Davis-Lorton MA, Jacobson KW, Gower RG, Broom C, Fitts D, Schranz J.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):77-84. doi: 10.1016/j.jaip.2013.09.008. Epub 2013 Nov 11.

PMID:
24565773
14.

Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks.

Lumry WR, Miller DP, Newcomer S, Fitts D, Dayno J.

Allergy Asthma Proc. 2014 Sep-Oct;35(5):371-6. doi: 10.2500/aap.2014.35.3783.

PMID:
25295804
15.

Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.

Craig TJ, Rojavin MA, Machnig T, Keinecke HO, Bernstein JA.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):211-5. doi: 10.1016/j.anai.2013.06.021. Epub 2013 Jul 16.

PMID:
23987198
16.

Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema.

Craig TJ, Wasserman RL, Levy RJ, Bewtra AK, Schneider L, Packer F, Yang WH, Keinecke HO, Kiessling PC.

J Clin Immunol. 2010 Nov;30(6):823-9. doi: 10.1007/s10875-010-9442-1. Epub 2010 Jul 16.

17.

C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.

Bewtra AK, Levy RJ, Jacobson KW, Wasserman RL, Machnig T, Craig TJ.

Allergy Asthma Proc. 2012 Sep-Oct;33(5):427-31. doi: 10.2500/aap.2012.33.3597.

PMID:
23026185
18.

Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.

Zuraw BL, Kalfus I.

Am J Med. 2012 Sep;125(9):938.e1-7. doi: 10.1016/j.amjmed.2012.02.020. Epub 2012 Jul 14.

PMID:
22800873
19.

Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.

Bork K, Craig TJ, Bernstein JA, Feuersenger H, Machnig T, Staubach P.

Allergy Asthma Proc. 2015 May-Jun;36(3):218-24. doi: 10.2500/aap.2015.36.3844. Epub 2015 Mar 23.

20.

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.

Riedl MA, Levy RJ, Suez D, Lockey RF, Baker JW, Relan A, Zuraw BL.

Ann Allergy Asthma Immunol. 2013 Apr;110(4):295-9. doi: 10.1016/j.anai.2013.02.007. Epub 2013 Mar 6.

PMID:
23535096
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk